Recursion will be featured in HighRes’ Lightning Talk at the NVIDIA GTC AI Conference & Expo happening March 16-19 in San Jose. Moderated by Stacie Calad-Thomson, Business Development Lead for Healthcare and Life Sciences at NVIDIA, the talk, “AI Agents, Robotics, and Digital Twins: The Full Stack of Self-Driving Labs and Biomanufacturing,” will showcase how AI, automation, and robotics are driving the new era of drug discovery and development. Presenter Ira Hoffman, CEO of HighRes Biosolutions, will share how they are collaborating with clinical stage AI drug discovery company Recursion on the potential for self-driving, high-throughput labs using advanced automation and orchestration. This collaboration is enabled by HighRes technologies including robotic perception, digital twins of laboratory environments, and natural language-driven lab orchestration that together support the foundation for self-driving laboratories. Other presenters include Fred Parietti, Co-Founder and CEO of Multiply Labs and Olga Ovchinnikova, Director of Product Management, Digital Labs, at Thermo Fisher Scientific.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RXRX:
- Recursion Pharmaceuticals, Inc (RXRX) Q4 Earnings Cheat Sheet
- Cathie Wood Invests $3M in CoreWeave Stock Ahead of Earnings and Adds $8.7M in Figma, Trims Exposure in DKNG
- Cathie Wood Scoops Up $24M in Figma, Sells DraftKings
- Cathie Wood Loads Up on Biotech Stocks While Trimming Several Tech Positions
- Cathie Wood’s ARK Investment buys 1.2M shares of Recursion Pharmaceuticals today
